NIH to meet over use of hydroxyurea for sickle cell disease
NIH to meet over use of hydroxyurea for sickle cell disease
How effective is the use of hydroxyurea to treat sickle cell anemia? The National Institutes of Health will be holding a consensus conference to address this issue. Sickle cell disease is an inherited blood disorder that affects up to 75,000 people in the United States, many of whom are from sub-Saharan Africa and other areas. The
Related Videos
Related Content
